Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study (vol 83, pg 15, 2023)Evan Y. Yu,Josep M. Piulats,Gwenaelle Gravis,Peter C. C. Fong,Tilman Todenhoefer,Brigitte Laguerre,Jose A. Arranz,Stephane Oudard,Christophe Massard,Julia Heinzelbecker,Luke T. Nordquist,Joan Carles,Michael P. Kolinsky,Marinela Augustin,Howard Gurney,Ali Tafreshi,Xin Tong Li,Ping Qiu,Christian H. Poehlein,Charles Schloss,Johann S. de BonoEUROPEAN UROLOGY(2023)引用 0|浏览34暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要